Elantas Beck India [ELANTAS] vs ACUTAAS CHEMICALS [ACUTAAS] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Elantas Beck India Ltd. wins in 9 metrics, ACUTAAS CHEMICALS LIMITED wins in 10 metrics, with 1 ties. ACUTAAS CHEMICALS LIMITED appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Elantas Beck India Ltd. | ACUTAAS CHEMICALS LIMITED | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 49.56 | 68.49 | Elantas Beck India Ltd. |
| Price-to-Book Ratio | 7.27 | 13.88 | Elantas Beck India Ltd. |
| Debt-to-Equity Ratio | 0.00 | 0.58 | Tie |
| PEG Ratio | 1.86 | 0.38 | ACUTAAS CHEMICALS LIMITED |
| EV/EBITDA | 38.65 | 50.77 | Elantas Beck India Ltd. |
| Profit Margin (TTM) | 17.43% | 23.62% | ACUTAAS CHEMICALS LIMITED |
| Operating Margin (TTM) | 18.21% | 35.82% | ACUTAAS CHEMICALS LIMITED |
| EBITDA Margin (TTM) | 18.21% | 35.82% | ACUTAAS CHEMICALS LIMITED |
| Return on Equity | 15.76% | 12.02% | Elantas Beck India Ltd. |
| Return on Assets (TTM) | 8.65% | 10.24% | ACUTAAS CHEMICALS LIMITED |
| Free Cash Flow (TTM) | $962.32M | $-763.00M | Elantas Beck India Ltd. |
| Dividend Yield | 0.07% | 0.09% | ACUTAAS CHEMICALS LIMITED |
| 1-Year Return | -8.06% | 184.72% | ACUTAAS CHEMICALS LIMITED |
| Price-to-Sales Ratio (TTM) | 8.64 | 16.14 | Elantas Beck India Ltd. |
| Enterprise Value | $66.55B | $193.96B | ACUTAAS CHEMICALS LIMITED |
| EV/Revenue Ratio | 7.85 | 15.96 | Elantas Beck India Ltd. |
| Gross Profit Margin (TTM) | 40.23% | 56.97% | ACUTAAS CHEMICALS LIMITED |
| Revenue per Share (TTM) | $1,069 | $148 | Elantas Beck India Ltd. |
| Earnings per Share (Diluted) | $186.45 | $34.97 | Elantas Beck India Ltd. |
| Beta (Stock Volatility) | -0.07 | -0.09 | ACUTAAS CHEMICALS LIMITED |
Elantas Beck India Ltd. vs ACUTAAS CHEMICALS LIMITED Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Elantas Beck India Ltd. | 2.66% | 1.50% | 7.35% | 30.58% | 1.70% | 4.38% |
| ACUTAAS CHEMICALS LIMITED | -1.55% | -6.62% | 13.39% | 43.03% | 89.90% | 76.87% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Elantas Beck India Ltd. | -8.06% | 49.57% | 159.68% | 554.83% | 520.63% | 3,580.18% |
| ACUTAAS CHEMICALS LIMITED | 184.72% | 175.78% | 175.78% | 175.78% | 175.78% | 175.78% |
Performance & Financial Health Analysis: Elantas Beck India Ltd. vs ACUTAAS CHEMICALS LIMITED
| Metric | ELANTAS | ACUTAAS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹72.13B | ₹196.08B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,212 | 353,873 |
| 90 Day Avg. Volume | 1,886 | 555,672 |
| Last Close | ₹9,815.00 | ₹3,096.70 |
| 52 Week Range | ₹7,111.00 - ₹14,250.00 | ₹1,059.00 - ₹3,444.30 |
| % from 52W High | -31.12% | -10.09% |
| All-Time High | ₹14,980.00 (Oct 14, 2024) | ₹3,444.30 (Jun 08, 2026) |
| % from All-Time High | -34.48% | -10.09% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.06% | 0.43% |
| Quarterly Earnings Growth | 0.32% | 1.40% |
| Financial Health | ||
| Profit Margin (TTM) | 0.17% | 0.24% |
| Operating Margin (TTM) | 0.18% | 0.36% |
| Return on Equity (TTM) | 0.16% | 0.12% |
| Debt to Equity (MRQ) | 0.00 | 0.58 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹1,271.86 | ₹172.59 |
| Cash per Share (MRQ) | ₹834.33 | ₹29.40 |
| Operating Cash Flow (TTM) | ₹1.27B | ₹1.09B |
| Levered Free Cash Flow (TTM) | ₹713.34M | ₹1.59B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.07% | 0.09% |
| Last 12-Month Dividend | ₹7.50 | ₹1.50 |
Valuation & Enterprise Metrics Analysis: Elantas Beck India Ltd. vs ACUTAAS CHEMICALS LIMITED
| Metric | ELANTAS (Apr 24, 2026) | ACUTAAS (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 49.56 | 68.49 |
| Forward P/E | 108.88 | 51.33 |
| PEG Ratio | 1.86 | 0.38 |
| Price to Sales (TTM) | 8.64 | 16.14 |
| Price to Book (MRQ) | 7.27 | 13.88 |
| Market Capitalization | ||
| Market Capitalization | ₹72.13B | ₹196.08B |
| Enterprise Value | ₹66.55B | ₹193.96B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.85 | 15.96 |
| Enterprise to EBITDA | 38.65 | 50.77 |
| Risk & Other Metrics | ||
| Beta | -0.07 | -0.09 |
| Book Value per Share (MRQ) | ₹1,271.86 | ₹172.59 |
Financial Statements Comparison: Elantas Beck India Ltd. vs ACUTAAS CHEMICALS LIMITED
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ELANTAS (2025) | ACUTAAS (2025) |
|---|---|---|
| Revenue/Sales | 8.46B | 10.00B |
| Cost of Goods Sold | 5.49B | 5.94B |
| COGS % of Revenue | 64.9% | 59.4% |
| Gross Profit | 2.97B | 4.06B |
| Gross Margin | 35.1% | 40.6% |
| Research & Development | 27.93M | N/A |
| Operating Income (EBIT) | 1.51B | 2.05B |
| Operating Margin | 17.9% | 20.5% |
| EBITDA | 1.85B | 2.49B |
| EBITDA Margin | 21.9% | 24.9% |
| Pre-Tax Income | 1.99B | 2.16B |
| Pre-Tax Income % of Revenue | 23.5% | 21.6% |
| Income Tax | 507.57M | 557.45M |
| Income Tax % of Revenue | 6.0% | 5.6% |
| Net Income (Profit) | 1.48B | 1.60B |
| Profit Margin | 17.5% | 16.0% |
Balance Sheet & Liquidity Metrics
| Metric | ELANTAS (2025) | ACUTAAS (2025) |
|---|---|---|
| Cash & Equivalents | 659.70M | 1.85B |
| Total Current Assets | 9.13B | 7.92B |
| Total Current Assets % of Revenue | 107.9% | 79.2% |
| Total Current Liabilities | 1.22B | 2.02B |
| Total Current Liabilities % of Revenue | 14.5% | 20.2% |
| Long-Term Debt | N/A | 47.54M |
| Long-Term Debt % of Revenue | 0.0% | 0.5% |
| Total Shareholders Equity | 10.08B | 13.20B |
| Retained Earnings | 9.32B | 4.53B |
| Retained Earnings % of Revenue | 110.1% | 45.3% |
| Property, Plant & Equipment | 1.62B | 445.33M |
Cash Flow Statement Comparison
| Metric | ELANTAS (2025) | ACUTAAS (2025) |
|---|---|---|
| Operating Cash Flow | 1.88B | 1.09B |
| Operating Cash Flow % of Revenue | 22.2% | 10.9% |
| Capital Expenditures | -306.88M | -1.95B |
| Free Cash Flow | 962.32M | -763.00M |
| FCF Margin | 11.4% | -7.6% |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ELANTAS | ACUTAAS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 7.93M | 81.87M |
| Float Shares | 1.86M | 47.87M |
| % Held by Insiders | 76.02% | 37.58% |
| % Held by Institutions | 12.14% | 27.19% |
| % Held by Public | 11.84% | 35.23% |
Dividend Analysis & Yield Comparison: Elantas Beck India Ltd. vs ACUTAAS CHEMICALS LIMITED
| Metric | ELANTAS | ACUTAAS |
|---|---|---|
| Last 12-Month Dividend | ₹7.50 | ₹1.50 |
| Last 12-Month Dividend Yield | 0.07% | 0.09% |
| 3-Year Avg Annual Dividend | ₹5.83 | ₹0.50 |
| 3-Year Avg Dividend Yield | 0.07% | 0.10% |
| 3-Year Total Dividends | ₹17.50 | ₹1.50 |
| Ex-Dividend Date | Apr 23, 2025 | Sep 18, 2025 |